| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2025 | Oct 17, 2025 | Keros Therapeutics, Inc. | Director | Sell | 15.0 | -4,787,331 | -99.78% | ✗ | $85M |
| Nov 17, 2020 | Nov 19, 2020 | Keros Therapeutics, Inc. | Director | Buy | 87.5 | +60,000 | 1.27% | ✗ | $3M |
| Apr 13, 2020 | Apr 13, 2020 | Keros Therapeutics, Inc. | Director | Buy | 100.0 | +437,499 | 10.18% | ✗ | $7M |
| Nov 11, 2019 | Nov 13, 2019 | 89bio, Inc. | Director | Buy | 100.0 | +250,000 | 100.00% | ✗ | $4M |